Blood
27 Nov 2007
Ozone Shuts Down Early Immune Response in Lungs and Body
As policy makers debate what levels of ozone in the air are safe for humans to breathe, studies in mice are revealing that the inhaled pollutant impairs the body’s first line of defence, making it more susceptible to subsequent foreign invaders, such as bacteria. While it has long been known…
Blood
26 Nov 2007
Unique Role for Blood Formation Gene Identified
All blood cell production in adults depends on the steady work of a vital gene that, if lost, results in early bone marrow failure, Dartmouth Medical School cancer geneticists have found. Their research reveals an unexpected role for the gene in sustaining the adult blood-forming system, and opens novel strategies…
Blood
20 Nov 2007
Nutrition for lowering cholesterol levels
Both dietary changes and drugs are used in the management of cholesterol levels. In most cases, the dietary approach is the first option, since dietary…
Blood
16 Nov 2007
Young Cancer Patients Failing to Receive the Best Cancer Treatment
Adolescent and young adult cancer patients are experiencing a reduced survival rate because they are failing to be involved in clinical trials, a meeting of national cancer experts will hear today. The UK Teenage Cancer Trust’s visiting professor, Dr David Walker, said young people who did take part in medical…
Blood
16 Nov 2007
New Anti-cancer Drug Now Subsidised by the Government
A government committee has recently announced its addition of Velcade (bortezomib) to the Australian Pharmaceutical Benefits Scheme (PBS). Velcade is a novel drug used to treat an aggressive blood cancer called multiple myeloma. Although the treatment is worth several thousands of dollars, patients can now access the drug at heavily…
Blood
16 Nov 2007
New Hope for Patients with Myeloma as Velcade is Added to the PBS
A novel therapy for advanced and progressive stages of multiple myeloma has become available on the Australian Pharmaceutical Benefits Scheme from November 1st 2007. This is fantastic news for sufferers of this rare and debilitating haematological cancer, whom normally face a poor prognosis without treatment. Multiple myeloma (MM) is a…
Blood
13 Nov 2007
New Anti-cancer Drug now Subsidised by the Government
A government committee has recently announced its addition of Velcade (bortezomib) to the Australian Pharmaceutical Benefits Scheme. Velcade is a novel drug used to treat an aggressive blood cancer called multiple myeloma. Until recently this drug was at prices far beyond what the average Australian could afford. Now the public…
Blood
13 Nov 2007
New Hope for Patients with Myeloma as Velcade is Added to the PBS
An expensive drug for the treatment of advanced and progressive stages of multiple myeloma has become available on the Australian Pharmaceutical Benefits Scheme from November 1st 2007. This is fantastic news for sufferers of this rare and debilitating haematological cancer, whom normally face a poor prognosis without treatment. Multiple myeloma…
Blood
18 Sep 2007
World Lymphoma Awareness Day
World Lymphoma Awareness Day will be held on 15th September around the world, in an effort to increase awareness of a disease which is set to increase in incidence by more than 30 percent between 2002 and 2011. Dr Anna Williamson, General Manager Research Advocacy and Patient Care at lymphoma…
